Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?-Reference-Cited by-同舟云学术

Of Mice and (Wo)Men: Is This Any Way to Test a New Drug?

Published:2008-02-20 Issue:6 Volume:26 Page:830-832
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Haddad Tufia C.¹,Yee Douglas¹

Affiliation:

1. University of Minnesota Cancer Center, Minneapolis, MN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.14.9062

Reference15 articles.

1. The mighty mouse: genetically engineered mouse models in cancer drug development

2. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer

3. Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

4. Can the pharmaceutical industry reduce attrition rates?

5. Osborne C, Hobbs K, Clark G: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45:584,1985-590,

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Depth of tumor implantation affects response to in situ vaccination in a syngeneic murine melanoma model;Journal for ImmunoTherapy of Cancer;2021-04

2. Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux;Journal of Cancer Research and Clinical Oncology;2019-07-10

3. Improving the Subcutaneous Mouse Tumor Model by Effective Manipulation of Magnetic Nanoparticles-Treated Implanted Cancer Cells;Annals of Biomedical Engineering;2018-08-03

4. Athymic Nude Mice as an Experimental Model for Cancer Treatment;Physiological Research;2016-12-15

5. Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model;PLOS ONE;2016-11-07